Coming back in 2019

London, UK

Tumour Models London returns for its 7th year while taking a reinvigorated approach towards closing the translational gap between predictable preclinical validation and successful clinical development.

The meeting will dive into how emerging and classical model systems continue to evolve the early-stage decision making to more effectively support the translation from bench to patient.

With new speakers, fresh case studies, and a more interactive format to the meeting agenda, Tumour Models London remains the leading forum for translational and preclinical scientists to really challenge how we optimise IO and Oncology-based research.

The key questions at the heart of the Tumour Models Series:

What new model and related technology initiatives are helping biopharma leaders drive translational and early-stage decision making

How biopharma leaders are balancing the need for model complexity and relevance with time, throughput and cost

What are the key criteria the leading biotech and pharma use to assess, select and characterise the array of tumour models

x

Highlights from Tumour Models London 2017

Media Partner

Sponsors

Our contact details

Venue Details

About Us

Hanson Wade's goal is to accelerate progress within organisations and across industries. Our primary method for achieving this is by creating exclusive business conferences that gather together the world's smartest thinkers and doers.